Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000187:drug effects; D002340:Carotid Artery Diseases; D002415:Cats; D004285:Dogs; D004558:Electric Stimulation; D004837:Epinephrine / Q000378:metabolism; D006146:Guanidines / Q000008:administration & dosage / Q000494:pharmacology*; D000860:Hypoxia; D007267:Injections; D007269:Injections, Intra-Arterial; D007278:Injections, Spinal; D008526:Medulla Oblongata / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D013116:Spinal Cord / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D014666:Vasomotor System / Q000187:drug effects*
D006146:Guanidines; D013565:Sympatholytics; D004837:Epinephrine